Literature DB >> 33880686

Tumor volume-adapted SUVN as an alternative to SUVpeak for quantification of small lesions in PET/CT imaging: a proof-of-concept study.

Mohammad Amin Mosleh-Shirazi1,2, Zahra Nasiri-Feshani3, Pardis Ghafarian4,5, Mehrosadat Alavi1,6, Gholamhasan Haddadi1,7, Ali Ketabi8,9.   

Abstract

PURPOSE: SUVpeak is a recommended quantification metric except for small lesions. We aimed to assess the averaged standard uptake value (SUVN) as an alternative to SUVpeak for small-lesion quantification.
MATERIALS AND METHODS: NEMA-like phantom images were reconstructed using OSEM, OSEM + PSF, OSEM + TOF and OSEM + TOF + PSF with two post-smoothing Gaussian filters for different background activity levels. SUVmax, SUVN (N = 5, 10, 15, 20, 25, 30, 35 or 40 hottest voxels), and SUVpeak, relative percent error, contrast recovery, and volume recovery coefficients were quantified and assessed.
RESULTS: SUVN did not have the limitations of SUVpeak for smaller lesions. In the smallest insert at 2.68 kBq/ml, optimum N values for OSEM, OSEM + PSF, OSEM + TOF and OSEM + TOF + PSF were 10, 5, 15, and 10 for SUVN, respectively. The same N values were obtained for metabolic tumor volumes (MTVs) for all reconstruction algorithms. At 5.30 kBq/ml, N = 5 was optimum for SUVN and MTVs. For the larger inserts, the optimum N increased and tended towards the maximum (similar to SUVpeak).
CONCLUSIONS: SUVN is more accurate than SUVmax or SUVpeak for small lesions, while being as accurate in larger ones. This harmonizing capacity of SUVN can be beneficial for the quantitative analysis of small tumor volumes.

Entities:  

Keywords:  FDG-PET/CT; Image reconstruction; SUV; Small lesions; Uptake quantification

Year:  2021        PMID: 33880686     DOI: 10.1007/s11604-021-01112-w

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  1 in total

Review 1.  Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET.

Authors:  Charlotte S van der Vos; Daniëlle Koopman; Sjoerd Rijnsdorp; Albert J Arends; Ronald Boellaard; Jorn A van Dalen; Mark Lubberink; Antoon T M Willemsen; Eric P Visser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-08       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.